Preview Company (Stock code) Date/time Event Presenter
Ariana Resources - 2021 Production Results, Resource and Reserve update
ARIANA RESOURCES (AAU) Thu, 03 Feb 2022 09:30 am (UK time) Ariana Resources - 2021 Production Results, Resource and Reserve update Dr Kerim Sener - Managing Director
UK Commercial Property REIT - Q4 NAV Presentation
UK COMMERCIAL PROPERTY REIT (UKCM) Thu, 03 Feb 2022 09:30 am (UK time) UK Commercial Property REIT - Q4 NAV Presentation Ken McCullagh - Chairman, UKCM
Arrow Exploration - Introduction Video
ARROW EXPLORATION CORP. (AXL) Wed, 02 Feb 2022 10:00 am (UK time) Arrow Exploration - Introduction Video Marshall Abbott - Chief Executive Officer
Open Orphan - COVID-19 Characterisation Study | Dr. Andrew Catchpole
OPEN ORPHAN (ORPH) Wed, 02 Feb 2022 10:00 am (UK time) Open Orphan - COVID-19 Characterisation Study | Dr. Andrew Catchpole Dr. Andrew Catchpole - Chief Scientist
Open Orphan - COVID-19 Characterisation Study | Cathal Friel
OPEN ORPHAN (ORPH) Wed, 02 Feb 2022 10:00 am (UK time) Open Orphan - COVID-19 Characterisation Study | Cathal Friel Cathal Friel - Executive Chairman
Anglo Pacific Group - Appointment of Marc Bishop Lafleche as CEO
ANGLO PACIFIC GROUP (APF) Mon, 31 Jan 2022 05:15 pm (UK time) Anglo Pacific Group - Appointment of Marc Bishop Lafleche as CEO Marc Bishop Lafleche - CEO
Porvair PLC - Full Year Results Analyst Presentation
PORVAIR PLC (PRV) Mon, 31 Jan 2022 09:30 am (UK time) Porvair PLC - Full Year Results Analyst Presentation PORVAIR - Management Team
Purplebricks Group plc - Half Year Results
PURPLEBRICKS GROUP (PURP) Mon, 31 Jan 2022 09:00 am (UK time) Purplebricks Group plc - Half Year Results Vic Darvey  - Chief Executive
Poolbeg Pharma - Licence Signed for Development of Oral Vaccine Delivery Platform
POOLBEG PHARMA (POLB) Mon, 31 Jan 2022 07:05 am (UK time) Poolbeg Pharma - Licence Signed for Development of Oral Vaccine Delivery Platform Jeremy Skillington - Chief Executive Officer
Dr. Martens plc - Q3 FY22 Trading Update
DR. MARTENS PLC (DOCS) Thu, 27 Jan 2022 09:30 am (UK time) Dr. Martens plc - Q3 FY22 Trading Update Kenny Wilson, CEO & Jon Mortimore, CFO